Deutsche Bank Ag\ Jounce Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.9 - $1.85 $6,659 - $13,688	7,399 Added 1.66%	452,119 $836,000
Q4 2022 Feb 13, 2023	SELL	$0.64 - $1.99 $40,119 - $124,745	-62,686 Reduced 12.35%	444,720 $493,000
Q3 2022 Nov 14, 2022	BUY	$2.73 - $4.92 $1.15 Million - $2.07 Million	421,671 Added 491.83%	507,406 $1.19 Million
Q2 2022 Aug 11, 2022	BUY	$2.8 - $7.67 $13,658 - $37,414	4,878 Added 6.03%	85,735 $260,000
Q1 2022 May 13, 2022	BUY	$6.01 - $8.54 $181,892 - $258,463	30,265 Added 59.82%	80,857 $549,000
Q4 2021 Feb 11, 2022	BUY	$7.11 - $9.64 $224,924 - $304,961	31,635 Added 166.88%	50,592 $422,000
Q3 2021 Nov 04, 2021	SELL	$5.04 - $8.73 $3,094 - $5,360	-614 Reduced 3.14%	18,957 $141,000
Q2 2021 Aug 11, 2021	BUY	$6.58 - $10.66 $54,975 - $89,064	8,355 Added 74.49%	19,571 $133,000
Q1 2021 May 13, 2021	SELL	$6.73 - $13.87 $7,005 - $14,438	-1,041 Reduced 8.49%	11,216 $115,000
Q4 2020 Feb 16, 2021	BUY	$6.37 - $10.33 $22,135 - $35,896	3,475 Added 39.57%	12,257 $86,000
Q3 2020 Nov 12, 2020	BUY	$4.58 - $10.95 $3,842 - $9,187	839 Added 10.56%	8,782 $72,000
Q2 2020 Aug 13, 2020	BUY	$4.17 - $7.58 $5,220 - $9,490	1,252 Added 18.71%	7,943 $55,000
Q1 2020 May 14, 2020	SELL	$2.91 - $8.7 $97,132 - $290,397	-33,379 Reduced 83.3%	6,691 $32,000
Q4 2019 Feb 14, 2020	SELL	$2.81 - $9.21 $122,212 - $400,561	-43,492 Reduced 52.05%	40,070 $348,000
Q3 2019 Nov 14, 2019	SELL	$3.33 - $4.93 $105,191 - $155,733	-31,589 Reduced 27.43%	83,562 $277,000
Q2 2019 Aug 14, 2019	SELL	$4.3 - $6.73 $205,114 - $321,027	-47,701 Reduced 29.29%	115,151 $569,000
Q1 2019 May 15, 2019	BUY	$3.43 - $6.87 $43,070 - $86,266	12,557 Added 8.35%	162,852 $1.01 Million
Q4 2018 Feb 14, 2019	BUY	$2.69 - $6.71 $108,358 - $270,292	40,282 Added 36.62%	150,295 $506,000
Q3 2018 Dec 21, 2021	BUY	$6.5 - $8.37 $57,427 - $73,948	8,835 Added 8.73%	110,013 $716,000
Q3 2018 Nov 14, 2018	BUY	$6.5 - $8.37 $370,662 - $477,299	57,025 Added 129.15%	101,178 $656,000
Q2 2018 Apr 21, 2020	BUY	$7.27 - $21.88 $72,576 - $218,428	9,983 Added 29.22%	44,153 $339,000
Q2 2018 Aug 14, 2018	BUY	$7.27 - $21.88 $57,680 - $173,595	7,934 Added 30.24%	34,170 $261,000
Q1 2018 Oct 18, 2019	BUY	$13.4 - $28.4 $113,819 - $241,229	8,494 Added 47.88%	26,236 $585,000
Q1 2018 May 15, 2018	SELL	$13.4 - $28.4 $200,115 - $424,125	-14,934 Reduced 45.7%	17,742 $395,000
Q4 2017 Feb 14, 2018	BUY	$12.52 - $17.82 $147,798 - $210,365	11,805 Added 56.56%	32,676 $416,000
Q3 2017 Nov 14, 2017	BUY	$11.17 - $16.99 $233,129 - $354,598	20,871	20,871 $323,000

Others Institutions Holding JNCE

# of Institutions

Shares Held

720K

Call Options Held

Put Options Held

View Full List

About Jounce Therapeutics, Inc.

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

More about JNCE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account